Table 1.
Baseline demographic data for the FAS population.
| 7 g RPS Dose | 3.5 g RPS Dose | Placebo | Total | |
|---|---|---|---|---|
| Number of Participants | 24 | 24 | 24 | 72 |
| Age (Year) # | ||||
| Mean (SD) | 36.6 (15.85) | 38.5 (14.63) | 39.1 (16.50) | 38.1 (15.49) |
| Median | 27.5 | 41.5 | 37.5 | 35.0 |
| Min, Max | 19, 64 | 20, 66 | 19, 66 | 19, 66 |
| Sex | ||||
| Male | 9 (37.5%) | 6 (25.0%) | 7 (29.2%) | 22 (30.6%) |
| Female | 15 (62.5%) | 18 (75.0%) | 17 (70.8%) | 50 (69.4%) |
| Race | ||||
| Indigenous | 0 (0.0%) | 0 (0.0%) | 1 (4.2%) | 1 (1.4%) |
| Asian | 3 (12.5%) | 3 (12.5%) | 0 (0.0%) | 6 (8.3%) |
| Black or African Canadian | 1 (4.2%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
| White | 19 (79.2%) | 21 (87.5%) | 23 (95.8%) | 63 (87.5%) |
| Other | 1 (4.2%) | 0 (0.0%) | 0 (0.0%) | 1 (1.4%) |
| Ethnicity | ||||
| Hispanic or Latino | 0 (0.0%) | 0 (0.0%) | 2 (8.3%) | 2 (2.8%) |
| Not Hispanic or Latino | 24 (100%) | 24 (100%) | 22 (91.7%) | 70 (97.2%) |
| Height (cm) | ||||
| Mean (SD) | 168.73 (8.919) | 165.60 (7.351) | 167.87 (9.682) | 167.40 (8.684) |
| Median | 167.05 | 165.10 | 166.25 | 166.20 |
| Min, Max | 151.5, 186.9 | 153.5, 186.5 | 151.3, 184.5 | 151.3, 186.9 |
| Weight (kg) | ||||
| Mean (SD) | 69.12 (13.836) | 73.40 (12.281) | 71.20 (13.811) | 71.24 (13.257) |
| Median | 65.20 | 74.60 | 71.00 | 71.40 |
| Min, Max | 47.4, 102.8 | 54.1, 98.2 | 47.0, 105.8 | 47.0, 105.8 |
| BMI (kg/m2) | ||||
| Mean (SD) | 24.10 (3.420) | 26.78 (4.291) | 25.14 (3.735) | 25.34 (3.938) |
| Median | 23.25 | 26.90 | 24.30 | 24.80 |
| Min, Max | 18.8, 31.8 | 19.6, 33.8 | 19.8, 33.3 | 18.8, 33.8 |
Age, sex, race, ethnicity, height, weight, and body mass index (BMI) for full analysis set (FAS) participants at baseline. # Age calculated based on the date of informed consent signed and date of birth. Standard deviation (SD) is indicated.